Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

Astrazeneca image

AstraZeneca battling ‘headwinds’

February 7, 2014
Sales and Marketing AstraZeneca, Soriot, farxiga, q4, results, xigduo

AstraZeneca is to shed another 550 jobs as its latest corporate restructure takes shape, bringing to 5,600 the number of …

News
Astrazeneca image

AstraZeneca ‘simplifies decision-making’

February 4, 2014
Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes

AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …

News
astrazeneca image

AZ bullish on its future – but analysts wary

January 15, 2014
Sales and Marketing AstraZeneca, Roche, analysts, jp morgan

AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …

News
forxiga image

FDA approves Farxiga

January 10, 2014
Sales and Marketing AstraZeneca, BMS, FDA, Forxiga, diabetes

The FDA has approved Farxiga, the diabetes treatment developed by AstraZeneca and Bristol-Myers Squibb as part of their soon-to-be-defunct diabetes …

News
Astrazeneca image

AstraZeneca strikes cancer vaccine pact

January 8, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology

AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …

News
Astrazeneca image

AZ and Horizon in cancer tie-up

January 8, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, horizon, medimunne

 AstraZeneca has signed a deal with British biotech firm Horizon Discovery to look at a number of genotypes to see …

News
BMS image

BMS sells diabetes stake to partner AstraZeneca

December 19, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, Onglyza, diabetes, komboglyze

AstraZeneca will buy out Bristol-Myers Squibb’s stake in its diabetes alliance in a potential $4.3 billion deal. AZ will pay …

News
astrazeneca image

AstraZeneca donates doomed lab to Plymouth University

December 12, 2013
Research and Development, Sales and Marketing AstraZeneca, lab, plymouth, university

AstraZeneca has pledged to donate its Devon-based Environmental Laboratory to Plymouth University, after announcing the site’s closure in October. The …

News
Vimovo image

AstraZeneca sells arthritis drug for $35 million

November 20, 2013
Sales and Marketing AstraZeneca, RA, arthritis, horizon, vimovo

AstraZeneca has sold rights to its arthritis treatment Vimovo to speciality pharma firm Horizon Pharma for $35 million.  AZ retains …

News
astrazeneca image

AstraZeneca ups cancer drug production at Alderley Park

November 11, 2013
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park

AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …

News
Astrazeneca image

More changes at the top as AstraZeneca profits slip

November 1, 2013
Sales and Marketing AstraZeneca, Crestor, Q3, profits

AstraZeneca’s third quarter revenues and profits fell below analysts’ expectations yesterday, but mitigated the news with the appointment of a …

News
marc_dunoyer_az1

AstraZeneca hires former GSK head as CFO

November 1, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, dunoyer

AstraZeneca has confirmed that Marc Dunoyer has been appointed chief financial officer and will join the company’s Board as an …

Appointment
astrazeneca image

AstraZeneca to close Brixham environmental lab

October 25, 2013
Manufacturing and Production API, AstraZeneca, brixham

AstraZeneca’s UK workers are facing more disruption following the company’s decision to close down a laboratory in Brixham focussing on …

News
astrazeneca image

Phoenix from Charnwood’s ashes

October 25, 2013
Research and Development, Sales and Marketing AstraZeneca, Charnwood, medilink

The shuttering of AstraZeneca’s R&D site at Charnwood in Leicestershire has had a positive effect on the region’s life sciences …

News
AstraZeneca imge

AZ begins late-stage trial of new cancer drug

October 22, 2013
Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025